Compared with unmodified E. coli and cell lines with low expression of SPARC protein, E. coli-BSA had stronger adhesion and targeting ability to bladder cancer cells with high expression of SPARC, but there is no significant difference in whether E. coli is modified in bladder cancer cell lines with low SPARC expression. This evidence concerns the gene SPARC and urinary bladder cancer.